Millions of people in the U.S. are affected by blood disorders.1 The accumulating epidemiologic evidence for non-malignant blood disorders continues to strengthen its consideration as a national public health priority. Although there is enormous potential for public health practice to reduce the disease burden and associated healthcare costs, the fiscal resources with which to do so are decreas...

An analysis was made of the distribution of various blood groups in subjects with affective disorders. A group of healthy subjects served as controls. The distribution showed lack of association of affective disorder and any blood groups.

Heparin-induced thrombocytopenia (HIT) is a life-threatening adverse reaction to heparin therapy that is characterized by thrombocytopenia and an increased risk of venous and arterial thrombosis. According to guidelines, in patients with strongly suspected or confirmed HIT all sources of heparin have to be discontinued and an alternative, nonheparin anticoagulant for HIT treatment must immediat...